Wordt geladen...
A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease.
BACKGROUND: Crohn's disease (CD) is a severe, lifelong disease characterised by inflammation of the gastrointestinal mucosa. The impact on patients and society is high as ill health can be lifelong and can negatively affect patients' quality of life. Costs to the NHS are high, particularly...
Bewaard in:
| Gepubliceerd in: | Health Technol Assess |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
NIHR Journals Library
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4781107/ https://ncbi.nlm.nih.gov/pubmed/21291629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta15060 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|